{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:54:15Z","timestamp":1790679255210,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,15]],"date-time":"2011-06-15T00:00:00Z","timestamp":1308096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0020534","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T16:04:16Z","timestamp":1308326656000},"page":"e20534","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy"],"prefix":"10.1371","volume":"6","author":[{"given":"Andreas D.","family":"Kistler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Siwy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Breunig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Jeevaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Scherl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralynn A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mischak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf P.","family":"W\u00fcthrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L.","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.","volume":"93","author":"WR Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ajmg.a.30123","article-title":"Inheritance of most X-linked traits is not dominant or recessive, just X-linked.","volume":"129A","author":"WB Dobyns","year":"2004","journal-title":"Am J Med Genet A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1136\/jmg.40.4.e38","article-title":"Clinical presentation in female patients with Fabry disease.","volume":"40","author":"N Guffon","year":"2003","journal-title":"J Med Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy.","volume":"138","author":"RJ Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2215\/CJN.02490607","article-title":"Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test.","volume":"3","author":"J Andrade","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry's disease.","volume":"345","author":"CM Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial.","volume":"285","author":"R Schiffmann","year":"2001","journal-title":"Jama"},{"key":"ref8","first-page":"CD006663","article-title":"Enzyme replacement therapy for Anderson-Fabry disease.","volume":"5","author":"RP El Dib","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ymgme.2005.01.007","article-title":"Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry.","volume":"85","author":"T Kitagawa","year":"2005","journal-title":"Mol Genet Metab"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cca.2009.02.016","article-title":"An easy and sensitive method for determination of globotriaosylceramide (Gb3) from urinary sediment: utility for Fabry disease diagnosis and treatment monitoring.","volume":"403","author":"PA Rozenfeld","year":"2009","journal-title":"Clin Chim Acta"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-005-4415-x","article-title":"Monitoring enzyme replacement therapy in Fabry disease\u2013role of urine globotriaosylceramide.","volume":"28","author":"PD Whitfield","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/08035320510028111","article-title":"Is globotriaosylceramide a useful biomarker in Fabry disease?","volume":"94","author":"E Young","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1470-2045(06)70584-8","article-title":"Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.","volume":"7","author":"D Theodorescu","year":"2006","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/prca.200800024","article-title":"CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.","volume":"2","author":"JJ Coon","year":"2008","journal-title":"Proteomics Clin Appl"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy.","volume":"65","author":"C Whybra","year":"2004","journal-title":"Clin Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10408360902805261","article-title":"Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.","volume":"46","author":"J Metzger","year":"2009","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mas.20205","article-title":"Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments.","volume":"28","author":"H Mischak","year":"2009","journal-title":"Mass Spectrom Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1073\/pnas.0611315104","article-title":"Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities.","volume":"104","author":"DF Moore","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3109\/0886022X.2010.516859","article-title":"Study of urinary proteomes in Anderson-Fabry disease.","volume":"32","author":"L Vojtova","year":"2010","journal-title":"Ren Fail"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/prca.200600771","article-title":"Clinical Proteomics: a need to define the field and to begin to set adequate standards.","volume":"1","author":"H Mischak","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","article-title":"Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.","volume":"15","author":"P Kotanko","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5414\/CNP64281","article-title":"Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients.","volume":"64","author":"M Tanaka","year":"2005","journal-title":"Clin Nephrol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfl528","article-title":"A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population.","volume":"22","author":"M Merta","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2350-11-19","article-title":"Frequency of Fabry disease in male and female haemodialysis patients in Spain.","volume":"11","author":"P Gaspar","year":"2010","journal-title":"BMC Med Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.","volume":"366","author":"A Rolfs","year":"2005","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/STROKEAHA.109.570499","article-title":"Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study\u2013screening genetic conditions in Portuguese young stroke patients.","volume":"41","author":"MV Baptista","year":"2010","journal-title":"Stroke"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/STROKEAHA.110.579409","article-title":"Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease.","volume":"41","author":"R Brouns","year":"2010","journal-title":"Stroke"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy.","volume":"333","author":"S Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.","volume":"105","author":"B Sachdev","year":"2002","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy.","volume":"110","author":"C Chimenti","year":"2004","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.","volume":"34","author":"A Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cccn.2004.10.019","article-title":"Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers.","volume":"353","author":"GE Linthorst","year":"2005","journal-title":"Clin Chim Acta"},{"key":"ref33","article-title":"Urinary Total Globotriaosylceramide and Isoforms to Identify Women With Fabry Disease: A Diagnostic Test Study.","author":"E Paschke","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.cca.2010.07.038","article-title":"How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?","volume":"411","author":"C Auray-Blais","year":"2010","journal-title":"Clin Chim Acta"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/HJH.0b013e32833d81b7","article-title":"Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals.","volume":"28","author":"C Delles","year":"2010","journal-title":"J Hypertens"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.2009.93","article-title":"Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease.","volume":"76","author":"AD Kistler","year":"2009","journal-title":"Kidney Int"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1074\/mcp.M800529-MCP200","article-title":"Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.","volume":"8","author":"M Haubitz","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1158\/1078-0432.CCR-09-0226","article-title":"Prediction of muscle-invasive bladder cancer using urinary proteomics.","volume":"15","author":"E Schiffer","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1074\/mcp.M110.001917","article-title":"Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.","volume":"9","author":"DM Good","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1681\/ASN.2007091025","article-title":"Urinary proteomics in diabetes and CKD.","volume":"19","author":"K Rossing","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s10545-008-0900-3","article-title":"Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy.","volume":"31","author":"P Vylet'al","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1021\/pr070328s","article-title":"Practical points in urinary proteomics.","volume":"6","author":"V Thongboonkerd","year":"2007","journal-title":"J Proteome Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/elps.200410140","article-title":"Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches.","volume":"26","author":"S Wittke","year":"2005","journal-title":"Electrophoresis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rcm.1294","article-title":"Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption\/ionization and capillary electrophoresis\/mass spectrometry.","volume":"18","author":"N Neuhoff","year":"2004","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/elps.200400208","article-title":"Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine.","volume":"26","author":"D Theodorescu","year":"2005","journal-title":"Electrophoresis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/pr800401m","article-title":"Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease.","volume":"8","author":"J Jantos-Siwy","year":"2009","journal-title":"J Proteome Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/bioinformatics\/btf877","article-title":"Identifying differentially expressed genes using false discovery rate controlling procedures.","volume":"19","author":"A Reiner","year":"2003","journal-title":"Bioinformatics"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nm1384","article-title":"Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis.","volume":"12","author":"S Decramer","year":"2006","journal-title":"Nat Med"},{"key":"ref49","first-page":"318","author":"J DeLeo"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/elps.200500827","article-title":"Biomarker discovery by CE-MS enables sequence analysis via MS\/MS with platform-independent separation.","volume":"27","author":"P Zurbig","year":"2006","journal-title":"Electrophoresis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0020534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T21:41:20Z","timestamp":1540244480000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0020534"}},"subtitle":[],"editor":[{"given":"Iris","family":"Schrijver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,15]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0020534","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,15]]}}}